Federal Register - July 8, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
36142
Federal Register / Vol. 86, No. 128 / Thursday, July 8, 2021 / Notices
A. Federal Reserve Bank of St. Louis Holly A. Rieser, Manager P.O. Box 442, St. Louis, Missouri 631662034.
Comments can also be sent electronically to Comments.applications@stls.frb.org:
1. John B. Allee, individually, and as trustee of the John B. Allee Heritage Trust, both of Tipton, Missouri; and Lori A. Woratzeck, as trustee of the Lori A.
Woratzeck Heritage Trust, both of California, Missouri; to become members of the Allee Family Control Group, a group acting in concert, to retain voting shares of Latham Bancshares, Inc., and thereby indirectly retain voting shares of The Tipton Latham Bank, National Association, both of Tipton, Missouri.
Board of Governors of the Federal Reserve System, July 2, 2021.
Michele Taylor Fennell, Deputy Associate Secretary of the Board.
FR Doc. 202114577 Filed 7721; 8:45 am BILLING CODE P
GENERAL SERVICES
ADMINISTRATION
Notice-PBS202104; Docket No. 2020
0002; Sequence No. 14
Revised Notice of Intent/Revised Project Action and Notice of Availability for Land Ports of Entry LPOE
Public Buildings Service PBS, Pacific Rim Division, General Services Administration GSA.
ACTION: Notice.
AGENCY:
GSA has prepared a Final Environmental Assessment EA and separate Finding of No Significant Impact FONSI which analyzed the potential impacts from the proposed construction of the Federal Motor Carrier Safety Administration FMCSA
standalone bus inspection facility at the San Ysidro Land Port of Entry LPOE in San Diego, California. The two alternatives analyzed include: New Basic Facility Buildout; No Build Action. GSA is advising the public that the Final EA and FONSI are available for public comment.
DATES: Due to the COVID19 pandemic and to ensure the safety of the public, a formal, in-person public meeting will not be held to solicit comments and provide information about the Final EA
and FONSI.
ADDRESSES: The Final EA can be viewed on the GSA website at www.gsa.gov/
r9fmcsa. In addition, copies may be obtained by calling or writing to the individual listed in this notice under
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:47 Jul 07, 2021
Jkt 253001
the FOR FURTHER INFORMATION CONTACT
section.
We will consider all comments that we receive on or before Monday, August 9, 2021. You may submit comments by either of the following methods:
Electronic Mail: osmahn.kadri@
gsa.gov.
Postal Mail/Commercial Delivery:
Send your comment to: Tina Sekula, JMT Inc., 1130 Situs Court, Suite 200, Raleigh, NC 27606.
FOR FURTHER INFORMATION CONTACT:
Email: Osmahn Kadri at osmahn.kadri@gsa.gov.
Telephone: 415 5223617.
NOTE PLEASE DO NOT MAIL
COMMENTS VIA THE U.S. POSTAL
SERVICE USPS TO THE GSA
MAILING ADDRESS AT THIS TIME.
USPS MAIL CAN BE SENT TO JMT INC
AT THE ADDRESS ABOVE.
SUPPLEMENTARY INFORMATION: The Final EA and FONSI have been prepared to comply with the National Environmental Policy Act NEPA of 1969, as amended 42 U.S. Code U.S.C.
4321, as implemented by Council on Environmental Quality CEQ
regulations 40 Code of Federal Regulations CFR 15001508, and policies of the GSA as the lead federal agency. The EA process provides steps and procedures to evaluate the potential social, economic, and environmental impacts from the construction of the proposed FMCSA Bus Inspection Facility at the San Ysidro LPOE while providing an opportunity for local, state, or federal agencies to provide input and/or comment through scoping, public information meetings, and/or a public hearing. The social, economic, and environmental considerations are evaluated and measured, as defined in the CEQ regulations, by their magnitude of impacts.
The bus inspection station allows for FMCSA to conduct inspections of buses entering the United States from Mexico.
FMCSA is required to conduct meaningful vehicle safety inspections and to accommodate vehicles placed out of service because of these inspections.
The current bus inspection operations at the San Ysidro LPOE lacks the necessary infrastructure for bus inspections and is not adequate to maintain regular inspections. Therefore, the LPOE does not efficiently address safety needs for the travelling public, FMCSA staff, nor the capacity needs identified in future traffic projections at the LPOE. The lack of dedicated bus inspection infrastructure exposes FMCSA to safety risks while conducting inspections and is not in conformance with current FMCSA safety standards.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
GSA proposes to construct a new FMCSA Bus Inspection facility on a 1.5acre parcel located north of the existing LPOE.
A public scoping meeting on the project was held on June 18, 2019.
Comments received during the meeting were considered by GSA in a Draft EA.
The Draft EA was made available for public comment on May 15, 2020.
Comments received during the onemonth comment period were considered by GSA in this Final EA. The FONSI, which is based on the Final EA, reflects the GSAs determination that construction of the proposed facility will not have a significant impact on the quality of the human or natural environment.
Russell Larson, Director, Portfolio Management Division, Pacific Rim Region, Public Buildings Service.
FR Doc. 202114510 Filed 7721; 8:45 am BILLING CODE 6820YFP
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration Docket Nos. FDA2019E5322 and FDA
2019E5323
Determination of Regulatory Review Period for Purposes of Patent Extension; PIQRAY
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug Administration FDA or the Agency has determined the regulatory review period for PIQRAY and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office USPTO, Department of Commerce, for the extension of a patent which claims that human drug product.
DATES: Anyone with knowledge that any of the dates as published see SUPPLEMENTARY INFORMATION are incorrect may submit either electronic or written comments and ask for a redetermination by September 7, 2021.
Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by January 4, 2022. See Petitions in the SUPPLEMENTARY INFORMATION section for more information.
SUMMARY:
E:FRFM08JYN1.SGM
08JYN1